The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Interest in Morgan Ashley

21 Oct 2019 07:00

RNS Number : 4625Q
Ashley House PLC
21 October 2019
 

21 October 2019

 

Ashley House plc

("Ashley House", the "Company" or the "Group")

 

Sale of Interest in Morgan Ashley

Re-focus on health and modular sectors

 

Ashley House plc, the health and community care property partner, announces that, further to the Trading Update released on 1st August 2019 and its process of reviewing various financing and strategic options, the Company has completed on a sale of its 50 per cent interest in Morgan Ashley Care Developments LLP ("Morgan Ashley"), to its joint venture partner Morgan Sindall Investments Limited ("MSI"), (the "Transaction").

Consideration for the Transaction is £2,000,000 payable in cash, £500,000 of which is to be deferred and expected to be received in instalments over the next twelve months including £200,000 which is dependent on the monies being generated from a particular scheme. In addition, the Company has signed an agreement with MSI for Ashley House to work on a pipeline of health, wellbeing and primary care developments across established health partnerships within which MSI are already working. The Company views this as an opportunity to work closely with the NHS and partners (very much the origins of the Ashley House business) to deliver much needed innovative health, wellbeing and primary care facilities.

As previously announced, delays to Morgan Ashley schemes reaching financial close have had a significant impact on the cash requirements of that business. Since the creation of Morgan Ashley it has required funding from Ashley House and MSI. Notwithstanding this, Ashley House's share of the profits from the Morgan Ashley joint venture contributed £310,000 in the year to 30 April 2018. Having explored a number of funding solutions including both debt and equity, the Company has concluded that the Transaction is in the best interests of shareholders. The Transaction will satisfy the short term cash requirements and enable Ashley House to restructure and return its focus to its key strengths as a developer of health and wellness buildings, as well as driving opportunities for its majority owned modular business, F1 Modular.

The terms of the Transaction restrict Ashley House from working in the elderly care housing sector for a period of three years, but the Board is developing a strategy to enable it to broaden its sphere of activity to adjacent markets, such as affordable housing and healthcare which are not restricted by the terms of the Transaction. Twelve staff members will transfer to Morgan Sindall under TUPE and the central management function of the Group is being restructured to be appropriate going forward, resulting in cost savings. The proceeds of the Transaction will be deployed within key areas of focus and used to support the Group's working capital requirements.

Antony Walters, Chief Executive, said: "The Board has reviewed funding and strategic opportunities available for the Company and has concluded that the Transaction and a re-focus on its key strengths in health development and modular construction are the most suitable options. We look forward to being able to exploit opportunities in these sectors and further developing the Company's strategic reach."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Ashley House plc

01628 600 340

Antony Walters

Jonathan Holmes

James Hathaway

WH Ireland Ltd

0207 220 1666

(Nominated Adviser and broker)

Adrian Hadden

James Sinclair-Ford

Darshan Patel

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAPEEAAKNFFF
Date   Source Headline
12th Dec 20134:36 pmRNSHolding(s) in Company
10th Dec 20137:00 amRNSInterim report 2013
30th Sep 20133:45 pmRNSShare Options
12th Sep 20131:42 pmRNSHolding(s) in Company
11th Sep 20134:56 pmRNSHolding(s) in Company
10th Sep 20137:00 amRNSDirector Dealings
27th Aug 20131:52 pmRNSAppointment of Chairman
29th Jul 201310:56 amRNSResult of AGM
5th Jul 20137:00 amRNSPosting of Annual Report & Notice of AGM
25th Jun 20137:00 amRNSPreliminary Results
14th Jun 20137:00 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSAppointment as Asset Manager and Sale of Projects
6th Jun 201310:00 amRNSAdmission as Member of the Social Stock Exchange
28th May 20133:16 pmRNSHolding(s) in Company
10th May 20137:00 amRNSTrading update, Board review and strategy progress
19th Apr 20133:44 pmRNSHolding(s) in Company
9th Apr 20133:40 pmRNSDirectorate Change
18th Mar 20134:53 pmRNSChange of Registered Office
11th Mar 20133:09 pmRNSDirectorate Changes
11th Feb 20131:26 pmRNSHolding(s) in Company
22nd Jan 20137:00 amRNSNominated Advisor & Broker / Report & Accounts
18th Dec 20127:00 amRNSInterim Results
20th Nov 201211:53 amRNSHolding(s) in Company
29th Oct 201212:42 pmRNSResult of AGM and statement
20th Sep 20127:00 amRNSReport and Accounts
25th Jul 20127:05 amRNSHolding(s) in Company
25th Jul 20127:00 amRNSPreliminary Results
11th Jun 20123:58 pmRNSHolding(s) in Company
7th Jun 201211:36 amRNSNotice of Results & Trading Update
29th May 201212:13 pmRNSDirectorate Change
1st May 20123:12 pmRNSTrading Update
25th Apr 201212:02 pmRNSDirector/PDMR Shareholding
12th Apr 20123:39 pmRNSDirector/PDMR Shareholding
21st Feb 20127:00 amRNSInterim Report and Accounts
9th Feb 20128:17 amRNSHolding(s) in Company
7th Feb 201211:18 amRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSInterim Report 2011
28th Nov 20112:46 pmRNSBoard Changes
31st Oct 201110:06 amRNSReport and Accounts
24th Oct 201111:54 amRNSResult of AGM and Statement
8th Sep 201111:28 amRNSHolding(s) in Company
26th Jul 20112:51 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSFinal Results
13th May 20117:00 amRNSTrading Update and Notice of Results
14th Apr 20119:42 amRNSHolding(s) in Company
29th Mar 20114:18 pmRNSHolding(s) in Company
17th Mar 20114:14 pmRNSExercise of Options
17th Mar 20117:00 amRNSHolding(s) in Company
7th Mar 20117:00 amRNSReceipt of Assura monies and Special Interim Divi
18th Feb 201112:00 pmRNSResponse to Assura statement re AH Medical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.